Vaso SG&A Expenses 2010-2024 | VASO

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Vaso sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Vaso sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$214.1B
Intuitive Surgical (ISRG)	$183.6B
Alcon (ALC)	$45.1B
IQVIA Holdings (IQV)	$40.2B
Edwards Lifesciences (EW)	$39.6B
IDEXX Laboratories (IDXX)	$34.7B
DexCom (DXCM)	$26.8B
Waters (WAT)	$23B
STERIS (STE)	$22.4B
SONOVA HOLDING (SONVY)	$21.9B
Hologic (HOLX)	$18.7B
Fresenius Medical Care AG KGaA (FMS)	$12.4B
Sysmex ADR (SSMXY)	$11.9B
Globus Medical (GMED)	$11.2B
Teleflex (TFX)	$9.4B
Penumbra (PEN)	$9B
Masimo (MASI)	$8.9B
Glaukos (GKOS)	$7.8B
PROCEPT BioRobotics (PRCT)	$5.1B
Integer Holdings (ITGR)	$4.5B
Inari Medical (NARI)	$3.1B
TransMedics (TMDX)	$2.9B
LivaNova (LIVN)	$2.8B
Veracyte (VCYT)	$2.8B
Nihon Kohden (NHNKY)	$2.5B
Tandem Diabetes Care (TNDM)	$2.2B
Elekta AB (EKTAY)	$2.2B
Integra LifeSciences Holdings (IART)	$2.1B
RxSight (RXST)	$2B
Alphatec Holdings (ATEC)	$1.3B